Generation of immunological memory by CRISPR-Cas systems
通过 CRISPR-Cas 系统生成免疫记忆
基本信息
- 批准号:9750114
- 负责人:
- 金额:$ 118.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-30 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAutoimmunityBacteriaBacteriophagesBase SequenceBiotechnologyCellsChromosomesClustered Regularly Interspaced Short Palindromic RepeatsDNAEcologyElementsEngineeringEventEvolutionFoundationsFrequenciesGenerationsGeneticGenetic DiseasesGenomeGenomicsHealthHumanHuman GeneticsImmune responseImmune systemImmunityImmunizationImmunologic MemoryInfectionInvadedKnowledgeMediatingMemoryMolecularMolecular GeneticsMutationNucleic Acid CleavageOrganismPathway interactionsPhasePlasmidsPopulationPostdoctoral FellowProcessProkaryotic CellsRNARecording of previous eventsRecordsResearch PersonnelSamplingSystemTherapeuticViralVirusbaseexperimental studygenome editingnext generation sequencingnucleasepreventprogramstechnology development
项目摘要
Project Summary
CRISPR-Cas loci consist of short DNA repeats separated by equally short sequences (known as spacers) that
match the genomes of prokaryotic viruses (phages) and plasmids and confer sequence-based immunity
against these elements. Immunity is mediated by small, antisense CRISPR RNA molecules (crRNAs) that are
transcribed from spacers and guide CRISPR-associated (Cas) nucleases to the invading nucleic acid for
cleavage and destruction. During my post-doctoral studies I pioneered the study of CRISPR-Cas systems to
establish the foundations of this bacterial immunity pathway. Using genetics, I determined that CRISPR-Cas
systems target DNA molecules in a sequence-specific manner, a study that was key to understand the
mechanisms of CRISPR immunity at the molecular level. This finding predicted the existence of RNA-
programmable Cas nucleases and their current applications to genome editing.
Upon plasmid or phage infection, CRISPR-Cas system incorporate new spacer sequences that match the
genome of the invader. This process records a memory of the infection that is subsequently used to generate
the crRNA guides for the Cas nucleases. While the molecular mechanisms behind the recognition and
cleavage of target sequences by the Cas nucleases are well understood, how the host can acquire new
spacers; i.e. the immunization phase of the CRISPR-Cas immune response, is still a mystery. In this proposal I
plan to study how the prokaryotic host acquires new spacer sequences from its invaders, using a combination
of molecular genetics and next-generation sequencing approaches. Fundamental questions such as (i) how
autoimmunity, or the acquisition of spacers from the host chromosome, is prevented; (ii) how fast is the
immunization process compared to the viral infectious cycle; (iii) which other cellular pathways, if any, assist
CRISPR immunization; (iv) how new spacer sequences are sampled from the invader's genome; and (v) how
the immunization process affects the evolution of the host population; are not yet answered. The proposed
studies will substantially advance our understanding of the molecular mechanisms underlying CRISPR-Cas
immunization and the impact that these loci have on the ecology and evolution of prokaryotes organisms that
harbor them. In addition, our experiments will require or allow us to engineer CRISPR-Cas systems that
perform spacer acquisition with high frequency. Such systems will facilitate the development of technologies
with applications that require the recording of specific cellular events into a specific genomic locus to enable
researchers following long cellular histories. Thus the proposed studies could provide new ground to exploit
CRISPR immunization for revolutionary biotechnological and/or therapeutic purposes.
项目概要
CRISPR-Cas 位点由由同样短的序列(称为间隔区)隔开的短 DNA 重复序列组成,
匹配原核病毒(噬菌体)和质粒的基因组并赋予基于序列的免疫力
反对这些要素。免疫是由小的反义 CRISPR RNA 分子 (crRNA) 介导的,这些分子
从间隔区转录并引导 CRISPR 相关 (Cas) 核酸酶到达入侵核酸
分裂和破坏。在我的博士后研究期间,我开创了 CRISPR-Cas 系统的研究
建立这种细菌免疫途径的基础。利用遗传学,我确定 CRISPR-Cas
系统以特定序列的方式靶向 DNA 分子,这项研究对于理解 DNA 分子的关键
分子水平上的 CRISPR 免疫机制。这一发现预测了RNA的存在
可编程 Cas 核酸酶及其当前在基因组编辑中的应用。
质粒或噬菌体感染后,CRISPR-Cas 系统会结合新的间隔序列来匹配
入侵者的基因组。该过程记录了感染的记忆,随后用于生成
Cas 核酸酶的 crRNA 指导。虽然识别和识别背后的分子机制
Cas核酸酶对靶序列的切割已被充分理解,宿主如何获得新的
垫片;即 CRISPR-Cas 免疫反应的免疫阶段仍然是一个谜。在这个提案中我
计划研究原核宿主如何使用组合从其入侵者那里获取新的间隔序列
分子遗传学和下一代测序方法。基本问题,例如 (i) 如何
防止自身免疫或从宿主染色体获得间隔区; (ii) 速度有多快
免疫过程与病毒感染周期的比较; (iii) 哪些其他细胞途径(如果有的话)可以提供帮助
CRISPR免疫; (iv) 如何从入侵者的基因组中取样新的间隔序列; (v) 如何
免疫过程影响宿主种群的进化;尚未得到答复。拟议的
研究将极大地增进我们对 CRISPR-Cas 分子机制的理解
免疫以及这些位点对原核生物的生态和进化的影响
庇护他们。此外,我们的实验将需要或允许我们设计 CRISPR-Cas 系统,
以高频执行间隔获取。这样的系统将促进技术的发展
需要将特定细胞事件记录到特定基因组位点的应用程序
研究人员追踪长期的细胞历史。因此,拟议的研究可以提供新的利用基础
用于革命性生物技术和/或治疗目的的 CRISPR 免疫。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Luciano A Marraffini其他文献
Luciano A Marraffini的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Luciano A Marraffini', 18)}}的其他基金
Spacer acquisition during the type III-A CRISPR-Cas immune response
III-A 型 CRISPR-Cas 免疫反应期间间隔区的获取
- 批准号:
10638980 - 财政年份:2023
- 资助金额:
$ 118.65万 - 项目类别:
Generation of immunological memory by CRISPR-Cas systems
通过 CRISPR-Cas 系统生成免疫记忆
- 批准号:
9340801 - 财政年份:2017
- 资助金额:
$ 118.65万 - 项目类别:
Generation of immunological memory by CRISPR-Cas systems
通过 CRISPR-Cas 系统生成免疫记忆
- 批准号:
10231123 - 财政年份:2017
- 资助金额:
$ 118.65万 - 项目类别:
Using CRISPR immunity to prevent the spread of virulence traits among pathogens
利用 CRISPR 免疫来防止病原体毒力特征的传播
- 批准号:
8356936 - 财政年份:2012
- 资助金额:
$ 118.65万 - 项目类别:
相似国自然基金
PEBP4通过下调TRAF6泛素化抑制自身免疫性慢性非细菌性前列腺炎的作用及机制研究
- 批准号:82360155
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
CD19+CD11b+B细胞在自身免疫性肠炎中的分化机制以及调节作用研究
- 批准号:31770992
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
依赖于肠腔溶菌酶的细菌配体对免疫系统的调控
- 批准号:31730028
- 批准年份:2017
- 资助金额:317.0 万元
- 项目类别:重点项目
Sox2作为细菌DNA传感器介导中性粒细胞自噬在ANCA相关性血管炎中的作用及机制研究
- 批准号:81571604
- 批准年份:2015
- 资助金额:54.0 万元
- 项目类别:面上项目
以细菌外毒素B亚单位为载体的口服免疫耐受实验研究
- 批准号:39570676
- 批准年份:1995
- 资助金额:8.0 万元
- 项目类别:面上项目
相似海外基金
Molecular mechanisms of memory formation and tolerance in CRISPR-Cas systems
CRISPR-Cas系统中记忆形成和耐受的分子机制
- 批准号:
10570544 - 财政年份:2023
- 资助金额:
$ 118.65万 - 项目类别:
Understanding and leveraging immunometabolism to combat Clostridioides difficile infection
了解并利用免疫代谢来对抗艰难梭菌感染
- 批准号:
10750341 - 财政年份:2023
- 资助金额:
$ 118.65万 - 项目类别:
Regulation of TLR signaling in anti-commensal B cell responses and mucosal inflammation
抗共生 B 细胞反应和粘膜炎症中 TLR 信号传导的调节
- 批准号:
10675251 - 财政年份:2023
- 资助金额:
$ 118.65万 - 项目类别:
Leveraging early-life events to promote tolerance to autoimmunity
利用生命早期事件促进对自身免疫的耐受
- 批准号:
10853727 - 财政年份:2023
- 资助金额:
$ 118.65万 - 项目类别:
Leveraging early-life microbes to prevent type 1 diabetes
利用生命早期微生物预防 1 型糖尿病
- 批准号:
10659611 - 财政年份:2023
- 资助金额:
$ 118.65万 - 项目类别: